Ask AI
Evolving Strategies in cSCC

CE / CME

From Recurrence to Prevention: Evolving Strategies in Cutaneous Squamous Cell Carcinoma

Physician Assistants/Physician Associates: 0.25 AAPA Category 1 CME credit

Pharmacists: 0.25 contact hour (0.025 CEUs)

Physicians: maximum of 0.25 AMA PRA Category 1 Credit

Nurse Practitioners/Nurses: 0.25 Nursing contact hour

Released: December 31, 2025

Expiration: June 30, 2026

Pretest

Progress
1 2 3
Course Completed
Please answer the questions below.
1.

In which of the following postoperative scenarios is adjuvant cemiplimab indicated to reduce the risk of recurrence following surgery and radiation in a patient with cutaneous squamous cell carcinoma (cSCC)?